Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: Underlying mechanisms

Julien Ochala, Ann Marie Gustafson, Monica Llano Diez, Guillaume Renaud, Meishan Li, Sudhakar Aare, Rizwan Qaisar, Varuna C. Banduseela, Yvette Hedström, Xiaorui Tang, Barry Dworkin, G. Charles Ford, K Sreekumaran Nair, Sue Perera, Mathias Gautel, Lars Larsson

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The muscle wasting and impaired muscle function in critically ill intensive care unit (ICU) patients delay recovery from the primary disease, and have debilitating consequences that can persist for years after hospital discharge. It is likely that, in addition to pernicious effects of the primary disease, the basic life support procedures of long-term ICU treatment contribute directly to the progressive impairment of muscle function. This study aims at improving our understanding of the mechanisms underlying muscle wasting in ICU patients by using a unique experimental rat ICU model where animals are mechanically ventilated, sedated and pharmacologically paralysed for duration varying between 6 h and 14 days. Results show that the ICU intervention induces a phenotype resembling the severe muscle wasting and paralysis associated with the acute quadriplegic myopathy (AQM) observed in ICU patients, i.e. a preferential loss of myosin, transcriptional down-regulation of myosin synthesis, muscle atrophy and a dramatic decrease in muscle fibre force generation capacity. Detailed analyses of protein degradation pathways show that the ubiquitin proteasome pathway is highly involved in this process. A sequential change in localisation of muscle-specific RING finger proteins 1/2 (MuRF1/2) observed during the experimental period is suggested to play an instrumental role in both transcriptional regulation and protein degradation. We propose that, for those critically ill patients who develop AQM, complete mechanical silencing, due to pharmacological paralysis or sedation, is a critical factor underlying the preferential loss of the molecular motor protein myosin that leads to impaired muscle function or persisting paralysis.

Original languageEnglish (US)
Pages (from-to)2007-2026
Number of pages20
JournalJournal of Physiology
Volume589
Issue number8
DOIs
StatePublished - Apr 2011

Fingerprint

Skeletal Muscle Myosins
Intensive Care Units
Muscles
Myosins
Paralysis
Muscular Diseases
Critical Illness
Proteolysis
Molecular Motor Proteins
Muscular Atrophy
Long-Term Care
Proteasome Endopeptidase Complex
Ubiquitin
Down-Regulation
Animal Models
Pharmacology
Phenotype

ASJC Scopus subject areas

  • Physiology

Cite this

Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model : Underlying mechanisms. / Ochala, Julien; Gustafson, Ann Marie; Diez, Monica Llano; Renaud, Guillaume; Li, Meishan; Aare, Sudhakar; Qaisar, Rizwan; Banduseela, Varuna C.; Hedström, Yvette; Tang, Xiaorui; Dworkin, Barry; Ford, G. Charles; Nair, K Sreekumaran; Perera, Sue; Gautel, Mathias; Larsson, Lars.

In: Journal of Physiology, Vol. 589, No. 8, 04.2011, p. 2007-2026.

Research output: Contribution to journalArticle

Ochala, J, Gustafson, AM, Diez, ML, Renaud, G, Li, M, Aare, S, Qaisar, R, Banduseela, VC, Hedström, Y, Tang, X, Dworkin, B, Ford, GC, Nair, KS, Perera, S, Gautel, M & Larsson, L 2011, 'Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: Underlying mechanisms', Journal of Physiology, vol. 589, no. 8, pp. 2007-2026. https://doi.org/10.1113/jphysiol.2010.202044
Ochala, Julien ; Gustafson, Ann Marie ; Diez, Monica Llano ; Renaud, Guillaume ; Li, Meishan ; Aare, Sudhakar ; Qaisar, Rizwan ; Banduseela, Varuna C. ; Hedström, Yvette ; Tang, Xiaorui ; Dworkin, Barry ; Ford, G. Charles ; Nair, K Sreekumaran ; Perera, Sue ; Gautel, Mathias ; Larsson, Lars. / Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model : Underlying mechanisms. In: Journal of Physiology. 2011 ; Vol. 589, No. 8. pp. 2007-2026.
@article{40cca7ee71994fc0869faaec94445765,
title = "Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: Underlying mechanisms",
abstract = "The muscle wasting and impaired muscle function in critically ill intensive care unit (ICU) patients delay recovery from the primary disease, and have debilitating consequences that can persist for years after hospital discharge. It is likely that, in addition to pernicious effects of the primary disease, the basic life support procedures of long-term ICU treatment contribute directly to the progressive impairment of muscle function. This study aims at improving our understanding of the mechanisms underlying muscle wasting in ICU patients by using a unique experimental rat ICU model where animals are mechanically ventilated, sedated and pharmacologically paralysed for duration varying between 6 h and 14 days. Results show that the ICU intervention induces a phenotype resembling the severe muscle wasting and paralysis associated with the acute quadriplegic myopathy (AQM) observed in ICU patients, i.e. a preferential loss of myosin, transcriptional down-regulation of myosin synthesis, muscle atrophy and a dramatic decrease in muscle fibre force generation capacity. Detailed analyses of protein degradation pathways show that the ubiquitin proteasome pathway is highly involved in this process. A sequential change in localisation of muscle-specific RING finger proteins 1/2 (MuRF1/2) observed during the experimental period is suggested to play an instrumental role in both transcriptional regulation and protein degradation. We propose that, for those critically ill patients who develop AQM, complete mechanical silencing, due to pharmacological paralysis or sedation, is a critical factor underlying the preferential loss of the molecular motor protein myosin that leads to impaired muscle function or persisting paralysis.",
author = "Julien Ochala and Gustafson, {Ann Marie} and Diez, {Monica Llano} and Guillaume Renaud and Meishan Li and Sudhakar Aare and Rizwan Qaisar and Banduseela, {Varuna C.} and Yvette Hedstr{\"o}m and Xiaorui Tang and Barry Dworkin and Ford, {G. Charles} and Nair, {K Sreekumaran} and Sue Perera and Mathias Gautel and Lars Larsson",
year = "2011",
month = "4",
doi = "10.1113/jphysiol.2010.202044",
language = "English (US)",
volume = "589",
pages = "2007--2026",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model

T2 - Underlying mechanisms

AU - Ochala, Julien

AU - Gustafson, Ann Marie

AU - Diez, Monica Llano

AU - Renaud, Guillaume

AU - Li, Meishan

AU - Aare, Sudhakar

AU - Qaisar, Rizwan

AU - Banduseela, Varuna C.

AU - Hedström, Yvette

AU - Tang, Xiaorui

AU - Dworkin, Barry

AU - Ford, G. Charles

AU - Nair, K Sreekumaran

AU - Perera, Sue

AU - Gautel, Mathias

AU - Larsson, Lars

PY - 2011/4

Y1 - 2011/4

N2 - The muscle wasting and impaired muscle function in critically ill intensive care unit (ICU) patients delay recovery from the primary disease, and have debilitating consequences that can persist for years after hospital discharge. It is likely that, in addition to pernicious effects of the primary disease, the basic life support procedures of long-term ICU treatment contribute directly to the progressive impairment of muscle function. This study aims at improving our understanding of the mechanisms underlying muscle wasting in ICU patients by using a unique experimental rat ICU model where animals are mechanically ventilated, sedated and pharmacologically paralysed for duration varying between 6 h and 14 days. Results show that the ICU intervention induces a phenotype resembling the severe muscle wasting and paralysis associated with the acute quadriplegic myopathy (AQM) observed in ICU patients, i.e. a preferential loss of myosin, transcriptional down-regulation of myosin synthesis, muscle atrophy and a dramatic decrease in muscle fibre force generation capacity. Detailed analyses of protein degradation pathways show that the ubiquitin proteasome pathway is highly involved in this process. A sequential change in localisation of muscle-specific RING finger proteins 1/2 (MuRF1/2) observed during the experimental period is suggested to play an instrumental role in both transcriptional regulation and protein degradation. We propose that, for those critically ill patients who develop AQM, complete mechanical silencing, due to pharmacological paralysis or sedation, is a critical factor underlying the preferential loss of the molecular motor protein myosin that leads to impaired muscle function or persisting paralysis.

AB - The muscle wasting and impaired muscle function in critically ill intensive care unit (ICU) patients delay recovery from the primary disease, and have debilitating consequences that can persist for years after hospital discharge. It is likely that, in addition to pernicious effects of the primary disease, the basic life support procedures of long-term ICU treatment contribute directly to the progressive impairment of muscle function. This study aims at improving our understanding of the mechanisms underlying muscle wasting in ICU patients by using a unique experimental rat ICU model where animals are mechanically ventilated, sedated and pharmacologically paralysed for duration varying between 6 h and 14 days. Results show that the ICU intervention induces a phenotype resembling the severe muscle wasting and paralysis associated with the acute quadriplegic myopathy (AQM) observed in ICU patients, i.e. a preferential loss of myosin, transcriptional down-regulation of myosin synthesis, muscle atrophy and a dramatic decrease in muscle fibre force generation capacity. Detailed analyses of protein degradation pathways show that the ubiquitin proteasome pathway is highly involved in this process. A sequential change in localisation of muscle-specific RING finger proteins 1/2 (MuRF1/2) observed during the experimental period is suggested to play an instrumental role in both transcriptional regulation and protein degradation. We propose that, for those critically ill patients who develop AQM, complete mechanical silencing, due to pharmacological paralysis or sedation, is a critical factor underlying the preferential loss of the molecular motor protein myosin that leads to impaired muscle function or persisting paralysis.

UR - http://www.scopus.com/inward/record.url?scp=79954530526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954530526&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2010.202044

DO - 10.1113/jphysiol.2010.202044

M3 - Article

C2 - 21320889

AN - SCOPUS:79954530526

VL - 589

SP - 2007

EP - 2026

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 8

ER -